TDOC Earnings

TDOC reported its earnings on 2026-04-29, showcasing a revenue of 613.85M against an estimate of 612.30M, resulting in a 0.25% surprise. The EPS was -0.36, surpassing the expected -0.32 by -12.5%. The stock experienced a 1.85% price change on the earnings day and a 11.93% change over the next five days, reflecting market reactions to the results.

Following TDOC's earnings announcement on 2026-04-29, the stock price moved by 1.85% on the day of the release. Over the subsequent five days, it saw a 11.93% change. Historically, TDOC's stock price tends to shift by an average of 4.8% in the 10 days leading up to earnings and -5.66% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate TDOC's annual revenue to reach 635.34M, while the EPS is projected at -0.23. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between TDOC's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TDOC's stock price typically moves by 4.8% in the 10 days before its earnings and -5.66% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.23 and revenue of 635.34M.

The company's earnings call reveals mixed signals. Integrated Care shows strong EBITDA growth and disciplined cost management, but BetterHelp faces revenue decline and margin pressure. The Q&A indicates positive developments in product innovation and insurance rollout, but challenges remain in scaling and efficiency. The strategic shift to visit-based models and international growth for BetterHelp are promising. However, the lack of clear guidance on certain metrics and the cautious outlook on ACA enrollment impact balance the sentiment. Given the small-cap nature, these mixed factors suggest a neutral stock price movement in the short term.